Ebglyss (lebrikizumab-lbkz) - Eli Lilly
Zoryve (roflumilast cream) - Arcutis
Cibinqo (abrocitinib) - Pfizer
Opzelura (ruxolitinib cream) - Incyte
Vtama (tapinarof) - Organon
Adbry (tralokinumab-ldrm) - LEO Pharma, AstraZeneca
Rinvoq (upadacitinib) - AbbVie
Olumiant (baricitinib) - Eli Lilly
Nemluvio (nemolizumab-ilto) - Galderma
Dupixent (dupilumab) - Sanofi, Regeneron
Eucrisa (crisaborole) - Pfizer
http://www.ncbi.nlm.nih.gov/pubmed/42446802
 
Charles Lynde; H Chih-Ho Hong; Irina Turchin; Jensen Yeung; Julien Ringuet; Kim A Papp; Melinda J Gooderham; Vimal H Prajapati; Yvette Miller-Monthrope
 
Jul 15, 2026
 
Prev Next